GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
Boehringer and CDR-Life report data from geographic atrophy treatment trial
FDA grants IND clearance for Adaptin Bio’s Phase I glioblastoma therapy trial
Mpox declared public health emergency in Africa
WashU Medicine finds anti-clotting drugs fail to improve stroke care outcomes
IN8bio cuts staff and pipeline to focus on AML cell therapy
Lilly’s efsitora shows promise in Phase III type 2 diabetes trials
Allurion’s swallowable balloon leads to 13% weight reduction in teens
Analysis
View More
Themes
View MoreAs mpox spreads, ‘national governments have a moral responsibility to help’
Representatives of the WHO and the IFRC called for international cooperation to tackle the current mpox outbreak.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Ultromics’s EchoGo misses primary endpoint in heart disease trial
NHS report touts effectiveness of Skin Analytics’ DERM AI melanoma tool
Spectral AI hits enrollment goal at burn centres for AI-powered assessment tech
What is mpox and how big of a threat is it?